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Introduction
Embryonic development is a fine-tuned interplay of rapid cell 
growth and differentiation. It is governed by signaling processes 
that are coordinated in a spatiotemporal manner through inter-
actions with cytoskeletal and scaffold proteins such as keratins 
in epithelia. However, the function of keratins in spatiotemporal 
scaffolding and signaling control is unclear. K7, -8, -18, and -19 
represent the first keratins during mouse development and begin 
to form a primary cytoskeleton at nascent desmosomes in the 
trophectoderm (Jackson et al., 1980). From then on, these kera-
tins are present in all embryonic and extraembryonic epithelia. 
Owing to their redundancy, it has not been possible to assign and 
discriminate their mechanical and signaling functions during 
embryo development and in tissue homeostasis (Hesse et al., 2000; 
Tamai et al., 2000; Jaquemar et al., 2003). The former is high-
lighted by previous gene knockout (KO) studies, which have ar-
rived at contradictory results (Baribault et al., 1993; Magin et al., 
1998; Hesse et al., 2000; Tamai et al., 2000; Jaquemar et al., 
2003). Deletion of K8 caused an embryonic lethal phenotype at 
embryonic day (E) 12.5, which is associated with placental mal-
functions caused by maternal TNF-induced apoptosis (Baribault 
et al., 1993; Jaquemar et al., 2003). Deletion of K18 permitted 
normal development because of the presence of K19, illustrat-
ing functional redundancy, at least for these two keratins (Magin 
et al., 1998). The combined deletion of K18/K19 and of K8/K19, 
which eliminated redundancy, caused fragility of giant tropho-
blast cells followed by extensive hemorrhages, which led to 
death at E10 (Hesse et al., 2000; Tamai et al., 2000). This was 
  K
eratin intermediate filament proteins form cyto­
skeletal  scaffolds  in  epithelia,  the  disruption  of 
which  affects  cytoarchitecture,  cell  growth,  sur­
vival, and organelle transport. However, owing to redun­
dancy,  the  global  function  of  keratins  has  not  been 
defined in full. Using a targeted gene deletion strategy, 
we generated transgenic mice lacking the entire keratin 
multiprotein family. In this study, we report that without 
keratins,  embryonic  epithelia  suffer  no  cytolysis  and 
maintain apical polarity but display mislocalized desmo­
somes. All keratin­null embryos die from severe growth 
retardation at embryonic day 9.5. We find that GLUT1 
and ­3 are mislocalized from the apical plasma mem­
brane in embryonic epithelia, which subsequently acti­
vates  the  energy  sensor  adenosine  monophosphate 
kinase (AMPK). Analysis of the mammalian target of 
rapamycin (mTOR) pathway reveals that AMPK induction 
activates Raptor, repressing protein biosynthesis through 
mTORC1’s downstream targets S6 kinase and 4E­binding 
protein 1. Our findings demonstrate a novel keratin func­
tion upstream of mTOR signaling via GLUT localization 
and have implications for pathomechanisms and therapy 
approaches  for  keratin  disorders  and  the  analysis  of 
other gene families.
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Figure 1.  Constitutive deletion of KtyII
/ keratin gene locus. (A) Schematic representation of the keratin type II cluster. Green arrowheads identify type II   
keratin genes oriented in the direction of the tip. The pink arrowhead identifies the only type I keratin (Krt18) at the end of type II cluster. (B) 5-targeting 
vector (MHPN117k13; Adams et al., 2004). (C) 3-targeting vector (MHPP322c09; Adams et al., 2004). Gaps [GR] are introduced into the region of 
homology before targeting. (D) During homologous recombination, the gap is repaired. PCR primers to identify homologous recombinants spanned the gap 177 KERATINS REGULATE TRANSLATION VIA GLUT AND AMPK • Vijayaraj et al.
and the proximal vector sequences (Table S1). (E) Cre-mediated recombination between loxP sites in cis leading to deletion of the keratin cluster. Southern 
probes are indicated as bold bars in B–E. (F) Southern blot analysis of ES cell clones targeted at the 5 (i) and the 3 end (ii) with a probe that distinguishes 
BsrGI (B) and HincII (Hi) fragments in the WT and targeted allele, respectively. (G) Southern blot analysis of ES cells after Cre-mediated recombination 
using unique probes spanning the 5 and 3 hprt. Probes distinguish double-targeted 8.3-kb and recombined 4.9-kb HinDIII (H) fragments using the   
5 hprt probe (i) and double-targeted 14.3-kb and recombined 10.5-kb EcoRI (E) fragments using the 3 hprt probe (ii). (H) mRNA expression of keratins 
and vimentin (Vim) in E9.5 WT and mutant embryos. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as a normalization control. (I) Immuno-
fluorescence of K8/ K18 desmoplakin (DP) on sections of E9.5 WT and KO embryos. Bars, 10 µm.
 
interpreted to indicate a primary mechanical function of kera-
tins, which is analogous to that seen in skin epidermis (Fuchs and 
Cleveland, 1998; Hesse et al., 2000; Tamai et al., 2000; Kim and 
Coulombe, 2007; Magin et al., 2007).
To systematically analyze keratin functions during em-
bryo development, we exploited the genomic organization of 
keratin genes. The mouse type I and II keratin families are clus-
tered on two contigs, which are located on chromosomes 11 and 
15, respectively (Hesse et al., 2001, 2004; Schweizer et al., 
2006). In this study, we describe mice lacking the type II gene 
cluster. Given that the assembly of keratin filaments from hetero-
dimers requires one member from each family and that keratins 
are rapidly degraded in the absence of a dimerization partner, 
mice lacking the type II gene cluster should be devoid of the 
entire keratin multiprotein family.
Results and discussion
To test current hypotheses on keratin function in mouse devel-
opment, we used the Cre-loxP system (Ramírez-Solis et al., 
1995) to flox the type II keratin gene cluster spanning 0.68 Mb 
of the genome in mouse embryonic stem (ES) cells (Fig. 1 A; 
Hesse et al., 2004). Targeting constructs from the Mutagenic 
Insertion  and  Chromosome  Engineering  Resource  (MICER; 
Adams et al., 2004) were engineered with gaps to aid in inser-
tional targeting (Fig. 1, B and C; and Fig. S1 A). Southern blot-
ting confirmed correct targeting at a frequency of 8% (Fig. 1,   
F and G; and Fig. S1 A). Empty 3 and 5 hprt vectors labeled for 
in situ hybridization against spread chromosomes from double-
targeted ES cell clones identified double-targeted clones in cis 
(Fig. S1 B). The floxed gene cluster contained all type II kera-
tins and the type I keratin Krt18, which with K8 forms the first 
keratin pair during embryonic development (Fig. 1 A; Lu et al., 
2005), but no other known genes, including microRNA genes.
Cre-mediated deletion of the keratin type II cluster (Fig. 1,   
D and E) did not affect ES cell pluripotency, and mice with a 
constitutive deletion of the keratin type II cluster (KtyII
/) 
were generated. Deletion of all 27 keratin genes was confirmed 
by RT-PCR and immunofluorescence microscopy (Fig. 1, H and I; 
and Fig. 2). Consistent with the proteolytic sensitivity of type I 
keratins in the absence of their type II keratin binding partners, 
the sole embryonic type I keratin K19 was expressed at the 
mRNA but not at the protein level (Fig. 1 H and Fig. S1 D; 
Magin et al., 2007). Therefore, our mice lack all 54 mammalian 
keratins (Fig. 1 H). The type III intermediate filament protein 
vimentin, which is frequently up-regulated during epithelial-
mesenchymal transition after loss of keratin expression (Thiery, 
2002; Yang and Weinberg, 2008), was not up-regulated at the 
transcript or protein level, indicating that deletion of the KtyII
/ 
cluster did not grossly perturb epithelial cell morphology or 
function (Fig. S2). In support, the expression of the constitutive 
chaperone Hsc70, which can bind keratins (Liao et al., 1997; 
Betz et al., 2006), was unaltered. The stress-inducible Hsp70 
was not detectable (see Fig. 4 A). Furthermore, activity of MAPK, 
as examined by Western blotting of candidate target proteins, 
appeared largely unchanged (see Fig. 4 C).
All KtyII
/ mice died at E9.5 (Fig. S1 E). Because kera-
tins maintain tissue integrity by interacting with desmosomes 
to provide intercellular adhesion, we investigated the gross   
appearance and histology of E9.5 embryos. Unlike previous single 
or double keratin KO mice, which suffered from cytolysis and 
hemorrhages (Baribault et al., 1993; Hesse et al., 2000; Tamai 
et al., 2000), KtyII
/ embryos had intact embryonic and extra-
embryonic epithelia (Fig. 3, A–F). These findings suggest 
that keratins have no essential mechanical function until this 
stage of mouse development and that the phenotype of previous 
keratin KOs may result from dominant-negative effects. Yet, the 
desmosomes in KtyII
/ embryos were smaller and partially 
mislocalized (Figs. 1 I and 2, A and B), which is consistent with 
the involvement of keratins in desmosome assembly (Godsel 
et  al.,  2005).  During  epidermal  differentiation,  desmoplakin 
was reported to regulate microtubule organization through   
ninein (Lechler and Fuchs, 2005). Staining for ninein revealed a 
prominent localization along the plasma membrane of yolk sac 
tissue (not depicted) and at centrosomes in embryonic epithe-
lia (Fig. 2 C). Ninein-positive centrosomes retained their apical 
position in KtyII
/ embryos (Fig. 2 C), which is in agree-
ment with unaltered -tubulin staining (not depicted). This is 
in contrast to a previous study (Ameen et al., 2001), indicating   
other and possibly compensatory mechanisms involved in centro-
some positioning. The localization of the adherens junction 
protein epithelial cadherin (E-cadherin) and the tight junction– 
associated proteins ZO-1 and occludin were highly similar 
in both genotypes of embryos, indicating that actin-associated 
adhesion complexes and the actin cytoskeleton (not depicted) 
maintain epithelial integrity and polarity (Fig. 2, D–F).
KtyII
/ embryos exhibited a striking growth retardation, 
which started at E8.5 and was fully apparent 1 d later (Fig. 3, 
G–J). Before the onset of placenta formation at E9.5, the em-
bryo is fully dependent on the yolk sac for nutrient supply. The 
mammalian target of rapamycin (mTOR) C1 complex regulates 
protein synthesis by integrating growth factor signals and nutri-
ents. Stimulation of the mTORC1 complex up-regulates protein 
synthesis by phosphorylation of its downstream targets ribo-
somal protein S6 kinase (S6K) and eukaryotic initiation factor 
4E-binding protein 1 (4E-BP1; Wullschleger et al., 2006). We 
hypothesized that the embryonic mortality was caused by de-
fective energy metabolism in the yolk sac.JCB • VOLUME 187 • NUMBER 2 • 2009   178
more detailed analysis. Given that limited glucose supply is 
known to severely restrict embryo growth and to increase 
apoptosis (Schmidt et al., 2009) and that mTORC1 is nutri-
ent sensitive (Shaw and Cantley, 2006), we were prompted 
to investigate upstream regulators of mTORC1 that might 
depend on keratins.
Limited  nutrition  represses  growth  and  protein  bio-
synthesis, and early mouse embryos predominantly rely on 
glycolysis (Pantaleon and Kaye, 1998). Therefore, we analyzed 
the AMP kinase (AMPK), the cellular energy sensor which is 
phosphorylated when AMP levels are elevated (Hardie, 2007). 
Phosphorylated (P) AMPK inhibits the mTORC1 complex   
through its binding partner Raptor (Gwinn et al., 2008). Using 
phosphospecific antibodies, we found increases of 20% in 
In a metabolic labeling experiment, analysis of 
35S-labeled 
Met/Cys incorporation showed that protein biosynthesis was 
reduced by 48% in the yolk sac and by 45% in the em-
bryonic  tissue  of  KtyII
/  embryos  (Fig.  3  K).  Moreover, 
phosphorylation of the mTORC1 targets S6K and 4E-BP1 
was reduced (Fig. 4 D), and eIF2- phosphorylation was in-
creased (Fig. 4 B). mTORC1 activity is regulated by several 
mechanisms, among them sequestration through 14-3-3 pro-
teins. Previously, the skin keratin K17 was found to posi-
tively regulate protein biosynthesis and keratinocyte growth 
through 14-3-3–-mediated mTOR sequestration, suggest-
ing a distinct role of certain keratins in wound repair (Kim 
et al., 2006). Although we detected sufficient 14-3-3 protein 
by Western blotting, the small size of embryos prevented a 
Figure 2.  KtyII
/ embryos show reduced and mislocalized desmoplakin, whereas adherens junctions and cell polarity are unaltered. (A and B) Double 
immunolabeling of keratin and desmoplakin (DP) on yolk sac indicates altered distribution and size of desmosomes in the presence (A) and absence (B) of 
keratins in yolk sac tissue. (C) Ninein part of the microtubule-organizing center complex at the centrosomes is located apically in WT (C) and KO embryonic 
intestine (C). (D) Note the apical localization of occludin, a transmembrane protein of tight junctions. (E) Antibody staining of the tight junction marker ZO-1 
in the yolk sac revealed no changes in WT (E) compared with KtyII
/ (E) E9.5 embryos. (D and E) ZO-1 and occludin are located at the apical plasma 
membrane of the yolk sac and the intestine, respectively, indicating normal cell polarity. (F) Intact adherens junctions in mutants (F) and their WT littermates 
(F), as demonstrated by staining for E-cadherin (E-cad) in yolk sac tissues of E9.5 embryos. lu, lumen. Bars: (A–B and E–F) 10 µm; (C–D) 2 µm.179 KERATINS REGULATE TRANSLATION VIA GLUT AND AMPK • Vijayaraj et al.
These findings confirmed our hypothesis that nutrient short-
age, which can signal through AMPK, reduced protein syn-
thesis in KtyII
/ embryos.
P-AMPK and 30% in P-Raptor (Fig. 4, E and F). Further-
more,  we  detected  no  change  in  phosphorylation  of Akt, 
which is a positive regulator of mTOR signaling (Fig. 4 E).   
Figure 3.  KtyII
/ embryos exhibit severe growth retardation and apoptosis, resulting from reduced protein biosynthesis, but maintain tissue integrity. 
(A–F) Semithin sections through WT (A–C) and mutant (D–F) embryos were stained with H&E. Note the tissue integrity in overview sections through complete 
E9.5 embryo in the WT (A) and the KO (D) mice. Higher magnifications of the visceral yolk sac (B and E) and embryonic intestine (C and F) from WT and 
KO embryos at E9.5 confirmed tissue integrity. (G–J) Whole mount photographs of WT (G and I) and mutant (H and J) embryos dissected from the yolk 
sac at E8.5 (G and H) and E9.5 (I and J). KtyII
/ embryos were growth retarded by 50%. (K) Metabolic labeling of dissected WT and KtyII
/ embryos 
and corresponding yolk sac tissues with 
35S-labeled Met/Cys. (L) FACS analysis of apoptotic cells in WT and KO embryos. Apoptosis was analyzed with 
cleaved poly(ADP-ribose) polymerase (cPARP) staining, and epithelial cells were detected with E-cadherin (E-cad) labeling. Subsequently, the percentage of 
apoptotic epithelia cells was determined to be 10-fold increased in KO compared with WT embryos. *, P < 0.05; **, P < 0.005 (two-tailed t test). Error 
bars represent SEM. eb, embryonic blood; lu, lumen; m, mesothelium; ve, visceral endoderm. Bars: (A, D, and G–J), 100 µm; (B, C, E, and F), 10 µm.JCB • VOLUME 187 • NUMBER 2 • 2009   180
ever, KtyII
/ embryos failed to respond to either treatment, 
indicating an unsuccessful rescue. Their P-AMPK levels were 
similar to those of deoxyglucose-treated WT embryos, and 
their total AMPK levels were unchanged (Fig. 4 G). These 
findings strongly suggest that keratins participate in the regu-
lation of cellular glucose uptake.
Next, we performed a biochemical rescue experiment in 
which glucose was added to isolated KtyII
/ and wild-type 
(WT)  embryos  in  ex  vivo  culture;  the  metabolic  inhibitor 
deoxyglucose served as a negative control. In WT embryos,   
P-AMPK levels were decreased by 10% in 5 mM glucose and 
increased by 52% in deoxyglucose medium (Fig. 4 G). How-
Figure 4.  Depletion of keratins activates AMPK and Raptor as the result of impaired glucose transport. (A and C) 14-3-3, chaperones Hsc70/Hsp70 (A), 
and P (Thr)-MAPK/Cdk substrate levels (C) were found to be similar, comparing protein lysates of keratin WT and KtyII
/ E9.5 embryos by immunoblot-
ting. (B and D) Detection of total and phosphorylated (P) proteins in protein lysates of keratin WT and KtyII
/ E9.5 embryos by immunoblotting of three 
independent pools of embryo lysates. (E and F) E9.5 lysates were analyzed by Western blotting for changes in P-AMPK and Raptor in both genotypes. 
Total protein and phosphoprotein levels of AMPK and Raptor were quantified by densitometry and normalized to tubulin (n = 3; F). (G) E9.5 embryos were 
incubated at 37°C for 10 min in M2
 medium containing 5.5 mM glucose or 5.5 mM deoxyglucose or left untreated. E9.5 lysates were Western blotted 
for changes in the phosphoprotein levels of AMPK in KtyII
/ and WT littermates. Total phosphoprotein levels of AMPK were quantified by densitometry 
and normalized to tubulin (n = 3). *, P < 0.05 (two-tailed t test). Error bars represent SEM.181 KERATINS REGULATE TRANSLATION VIA GLUT AND AMPK • Vijayaraj et al.
Figure 5.  Keratins regulate AMPK activity through localization of GLUT1 and -3. (A and B) Double immunofluorescence of keratins and GLUT1 and -3 
(A and B) in WT yolk sac tissue. (A, A, B, and B) Yolk sacs of E9.5 WT and KtyII
/ embryos were analyzed for GLUT1 (A and A) and -3 (B and B) 
localization. Insets show enlargement of the region encompassing the plasma membrane. (C) mRNA expression of GLUT transporters in E9.5 WT and 
mutants. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as a normalization control. (D) Total GLUT1 and -3 protein levels in protein   
lysates of E9.5 keratin WT and KtyII
/ embryos. Error bars represent SEM. G, GLUT; T, tubulin. (E) Model for function of apical keratins in GLUT localiza-
tion. Our model suggests that full activation of mTORC1 depends on the correct localization of GLUT1 and -3 by subapical keratins in the mouse embryo. 
Bars, 10 µm.JCB • VOLUME 187 • NUMBER 2 • 2009   182
Glucose  transport  is  mainly  performed  by  energy- 
independent facilitative transporters of the GLUT family, which 
are expressed during blastocyst formation when embryos switch 
from pyruvate to glucose as the major energy source (Barbehenn 
et al., 1974). In early embryos, GLUT1 and -3 are the main 
transporters that regulate glucose distribution, and their KO 
causes severe growth retardation with increased apoptosis dur-
ing embryo development (Wang et al., 2006; Ganguly et al., 
2007; Schmidt et al., 2009). FACS sorting of trypsinized KtyII
/ 
embryos confirmed a 10-fold increase in apoptotic cells, indi-
cating a nutrition defect (Fig. 3 L). To analyze this further, dou-
ble immunofluorescence analysis with GLUT1 and -3 and 
K8/K18 antibodies were performed. This showed that GLUT1 
and -3 were predominantly localized to the apical plasma mem-
brane of the yolk sac. In WT yolk sacs, K8/K18 keratins were 
confined in the subapical region (Figs. 1 I and 5, A and B). Of 
note, subapical intermediate filament organization is evolution-
arily conserved down to Caenorhabditis elegans, where it is re-
quired for gut epithelial organization (Hüsken et al., 2008). 
In KtyII
/ embryos, GLUT1 and -3 levels at the apical plasma 
membrane of the yolk sac were markedly reduced, causing 
redistribution of the transporters throughout endodermal cells 
(Fig. 5, A, A, B, and B). In line with AMPK activation, their 
total transcript and protein levels were unaltered (GLUT1) or 
slightly elevated (GLUT3; Fig. 5, C and D). Our data lead to a 
model in which full activation of mTORC1 depends on the cor-
rect localization of GLUT1 and -3 by subapical keratins in the 
mouse embryo (Fig. 5 E).
These findings reveal a novel regulatory mechanism by 
which keratins coordinate cell growth and protein synthesis at the 
level of GLUT transporters. The highly regulated expression and 
subcellular organization of keratins strongly suggest their in-
volvement in growth regulation and protein targeting beyond 
embryo development, as demonstrated for K17 in skin wound 
healing and K8 in colonic epithelia (Toivola et al., 2004; Kim 
et al., 2006). Although the molecular mechanisms are not yet 
known, it is well established that the correct localization of cell 
adhesion proteins depends on keratins and vimentin (Godsel 
et al., 2005; Toivola et al., 2005; Nieminen et al., 2006). Possibly, 
keratins and vimentin orchestrate the local interaction of 14-3-3 
proteins with their multiple binding partners during organelle 
transport, cell polarity, and signaling. Furthermore, our data have 
far-ranging implications for the analysis of other large mamma-
lian gene families as they suggest that some of the previous single 
and  double  keratin  KOs  may  represent  gain-of-toxic-function 
phenotypes (Hesse et al., 2000; Tamai et al., 2000; Jaquemar 
et al., 2003; Magin et al., 2004). This implicates that the patho-
mechanisms underlying skin keratin disorders not only result 
from mechanical fragility but from disturbed regulation of cell 
growth and signaling, opening new therapeutic opportunities (Kim 
et al., 2006; Kerns et al., 2007; Roth et al., 2009).
Materials and methods
Targeting the 5 end of the keratin type II cluster
The 5 hprt vector clone MHPN117k13 (Adams et al., 2004) was used 
to target the 5 end of the type II keratin cluster. This contained an insert 
of 6.0 kb spanning 101,202,450–101,208,417 bp on chromosome 15. 
A gap of 1.5 kb was generated with unique restriction sites, NheI and 
Bsp119I, to yield 2.0- and 2.4-kb arms of homology (Figs. 1 A and S1 A). 
NotI linkers were introduced at the cut sites to obtain a NotI restriction 
site. The plasmid was linearized with NotI before targeting and trans-
fected (200 µg) into AB2.2 cells (gift from A. Bradley, Wellcome Trust 
Sanger Institute, Cambridge, England, UK) at 3 µF and 800 V. G418 
selection was initiated 24 h after targeting at 350 µg/ml. Neomycin-
resistant colonies were screened for homologous recombination; the plas-
mid without the gap served as a positive control. PCR primers spanned the 
gap region and vector backbone (Table S1). Eight clones that were PCR 
positive for the homologous recombination event were further confirmed 
by Southern blotting with a probe specific to the gap region (Table S1). 
Five were positive for the homologous recombination at the 5 end of the 
keratin type II cluster. Clone 2 was used to target the 3 end of the keratin 
type II cluster.
Targeting the 3 end of the keratin type II cluster
The insert from the MICER 5 hprt clone MHPN322c09 (Adams et al., 
2004) was excised from the vector at the AscI sites flanking the insert, 
cloned into an empty 3 hprt vector, and named MHPP322c09. This con-
tained  a  6.9-kb  insert  spanning  101,876,016–101,882,964  bp  on 
chromosome 15. A gap of 1.4 kb was generated with SacI restriction 
sites to yield 3.0- and 2.4-kb arms of homology (Fig. 1 B and Fig. S1 A). 
SacI was used to linearize the plasmid to target into the aforementioned 
clone 2. ES cells were targeted as described in the previous section and 
selected in 3 µg/ml puromycin 24 h after electroporation. 8 of 96 picked 
clones showed homologous recombination, as determined by PCR with 
primers spanning the gap region and vector backbone (Table S1). These 
clones were confirmed by Southern blot analysis with a 487-bp probe 
designed within the gap region (Table S1). All PCR-positive clones were 
correctly recombined at the 3 end of the keratin type II cluster, as con-
firmed by Southern blot analysis.
Identification of double-targeted cis ES clones by fluorescence  
in situ hybridization
Metaphase chromosome spreads on slides were performed as previously 
described (Henegariu et al., 2001). Empty 3 and 5 hprt vectors were la-
beled with biotin and digoxigenin, respectively, by nick translation and 
used for chromosomal in situ hybridization against spread chromosomes 
from double-targeted ES cell clones according to a standard protocol 
(Wrehlke et al., 1999). Red and green signals (or a yellow overlap) on a 
single chromosome confirmed the double targeting in cis (Fig. S1 B). One 
of the three double-targeted clones tested by fluorescence in situ hybridiza-
tion was confirmed to have the targeted constructs in cis. This clone was 
subjected to Cre expression.
Cre-mediated deletion of the keratin type II cluster
The double-targeted clone in cis was transiently transfected with 200 µg 
of CrePac vector (Taniguchi et al., 1998) using the identical conditions 
described in Targeting the 5 end of the keratin type II cluster. Selection 
with 1× hypoxanthine and thymine was initiated 24 h after transfection for 
10 d. 96 colonies were screened for deletion of the keratin cluster with 
primers specific to the 3 and 5 hprt regions. This was further confirmed 
by Southern blot analysis with probes specific to the 3 and 5 hprt regions. 
Two independent clones positive for the deleted cluster were used to gener-
ate male chimeras by blastocyst injections (gift from R. Maniu, Universität 
Bonn, Bonn, Germany). Male chimeras were outbred to C57BL/6 WT 
females to generate mice heterozygous for the keratin type II deletion. 
Heterozygous progeny were inbred to generate KtyII
/ mice.
RT-PCR and Western blotting
Total RNA was isolated from E9.5 embryos and yolk sacs with RNeasy 
Micro kits (QIAGEN). Reverse transcription was performed with RevertAid 
First Strand cDNA Synthesis kits (Fermentas). The primers and PCR condi-
tions have been described previously (Tonack et al., 2004; Lu et al., 2005). 
For vimentin cDNA synthesis, 2 µg of total RNA was reverse transcribed in 
a volume of 20 µl. PCR with Platinum Taq polymerase (Invitrogen) was per-
formed in 25-µl reactions containing 0.1 µl of template cDNA, according 
to the manufacturer’s protocol. PCR reactions were performed as follows: 
35 cycles at 94°C for 30 s, 65°C for 30 s, and 72°C for 20 s. The se-
quences of the primer pairs are outlined in Table S1.
Western blotting was performed as follows. Total protein was ex-
tracted in SDS-PAGE sample buffer (50 mM Na phosphate, pH 6.8, 5% 
SDS, 40 mM DTT, 5 mM EDTA, 5 mM EGTA, and 15% glycerol). The sam-
ples were heated for 5 min at 95°C, sonicated three times for 30 s and, in 
between intervals, kept for 30 s at 95°C; the procedure was repeated, and 183 KERATINS REGULATE TRANSLATION VIA GLUT AND AMPK • Vijayaraj et al.
Metabolic labeling
E9.5 embryos and yolk sacs were dissected from the uterus, and the head 
was retained for genotyping. Embryos and yolk sac were incubated sepa-
rately in Met-free Dulbecco’s modified Eagle’s medium (Invitrogen) contain-
ing 25 mM Hepes buffer, 10% dialyzed fetal calf serum, 1% nonessential 
amino acids, 1× Na pyruvate, and 1% Glutamax (all Invitrogen) at 37°C 
for 15 min to remove endogenous Met. The medium was discarded, and 
tissues were labeled with 100 µl of 
35S-labeled Met/Cys (1,000 Ci/mmol; 
0.1 mCi/ml) in Met-free Dulbecco’s modified Eagle’s medium for 1 h at 
37°C. The medium was aspirated, and tissues were washed in ice-cold 
PBS.  Proteins  were  precipitated  with  10%  trichloroacetic  acid,  and  in-
corporated radioactivity was measured by liquid scintillation. The rate of   
35S-labeled Met/Cys incorporation per minute per milligram of protein was 
calculated using the Bradford reagent (Bradford, 1976).
Glucose assay
E9.5 embryos and yolk sacs were dissected from the uterus. Embryos 
and yolk sac together were incubated in M2
 medium (94.59 mM NaCl,   
4.78 mM KCl, 1.19 mM KH2PO4, 1.19 MgSO4, 1.71 mM CaCl2, 4.0 mM 
NaHCO3, 21 mM Hepes, and 4 g/liter albumin bovine fraction V; all from 
Sigma-Aldrich) without glucose or its metabolites, with 5.5 mM glucose 
(Sigma-Aldrich), or with 5.5 mM deoxyglucose (Sigma-Aldrich) for 10 min 
at 37°C. Subsequently, embryos were lysed in boiling Laemmli buffer and 
analyzed by Western blotting for total and P-AMPK levels.
Online supplemental material
Fig.  S1  shows  additional  characterizations  of  the  genetic  engineer-
ing at the keratin type II gene locus. Fig. S2 demonstrates that the de-
letion of keratins does not induce vimentin. Tables S1 and S2 provide 
the details of the primers and the antibodies, respectively, used in this 
study.  Online  supplemental  material  is  available  at  http://www.jcb 
.org/cgi/content/full/jcb.200906094/DC1.
We thank Prof. A. Bradley for providing the AB2.2 ES cell line, snlp feeder 
cell line, and MICER clones for targeting and Mrs. R. Maniu for the blastocyst 
injections. We gratefully thank Prof. J.B. Rattner for his gift of ninein antiserum 
and E. Endl, A. Dolf, and P. Wurst from the Flow Cytometry Core Facility at 
the Institute for Molecular Medicine and Experimental Immunology, University 
of Bonn. We thank our former colleague Dr. M. Hesse for stimulating ideas 
and input in the experimental design. We are grateful to our colleagues M. 
Hatzfeld and M. Hoch for critical input. Also, we thank colleagues who pro-
vided antibodies.
This project was funded by Deutsche Forschungsgemeinschaft (German 
Research Council MA 1316/7) grant SFB832, Bonfor (Cytoskeletal Research 
Group), and the Bonner Forum Biomedizin.
Submitted: 15 June 2009
Accepted: 2 September 2009
References
Adams, D.J., P.J. Biggs, T. Cox, R. Davies, L. van der Weyden, J. Jonkers, J. 
Smith, B. Plumb, R. Taylor, I. Nishijima, et al. 2004. Mutagenic insertion 
and chromosome engineering resource (MICER). Nat. Genet. 36:867–
871. doi:10.1038/ng1388
Ameen, N.A., Y. Figueroa, and P.J. Salas. 2001. Anomalous apical plasma mem-
brane phenotype in CK8-deficient mice indicates a novel role for inter-
mediate  filaments  in  the  polarization  of  simple  epithelia. J.  Cell  Sci. 
114:563–575.
Barbehenn, E.K., R.G. Wales, and O.H. Lowry. 1974. The explanation for the 
blockade of glycolysis in early mouse embryos. Proc. Natl. Acad. Sci. 
USA. 71:1056–1060. doi:10.1073/pnas.71.4.1056
Baribault,  H.,  J.  Price,  K.  Miyai,  and  R.G.  Oshima.  1993.  Mid-gestational   
lethality  in  mice  lacking  keratin  8.  Genes  Dev.  7:1191–1202.  doi:10. 
1101/gad.7.7a.1191
Betz, R.C., L. Planko, S. Eigelshoven, S. Hanneken, S.M. Pasternack, H. Bussow, 
K. Van Den Bogaert, J. Wenzel, M. Braun-Falco, A. Rutten, et al. 2006. 
Loss-of-function mutations in the keratin 5 gene lead to Dowling-Degos 
disease. Am. J. Hum. Genet. 78:510–519. doi:10.1086/500850
Bradford,  M.M.  1976. A  rapid  and  sensitive  method  for  the  quantitation  of   
microgram quantities of protein utilizing the principle of protein-dye bind-
ing. Anal. Biochem. 72:248–254. doi:10.1016/0003-2697(76)90527-3
Fuchs, E., and D.W. Cleveland. 1998. A structural scaffolding of intermediate 
filaments  in  health  and  disease.  Science.  279:514–519.  doi:10.1126/ 
science.279.5350.514
after an additional 10 min at 95°C, the insoluble material was removed by 
centrifugation. Total protein was determined by the protein quantification 
kit (Bio-Rad Laboratories), and extracts were loaded equally. Separation of 
total protein extracts was performed by standard procedures (8 and 10% 
SDS-PAGE). Proteins were electrotransferred to 0.1-µm nitrocellulose mem-
branes (GE Healthcare) by wet blotting in Towbin buffer (25 mM Tris-HCl, 
pH 8.8, 192 mM glycin, 0.1% SDS, and 10% methanol). Membranes 
were stained with 0.5% Ponceau S. Secondary antibodies were used with 
Super Signal (Thermo Fisher Scientific) as a substrate (Reichelt and Magin, 
2002). Antibodies and dilutions are listed in Table S2.
Histology and immunofluorescence analysis
Mouse concepti at different gestational ages were prepared. For light 
microscopy and immunofluorescence, tissues were snap frozen in isopen-
tane precooled at 80°C and cryosectioned (10 µm). Immunofluorescence 
analysis was performed as follows: tissues were snap frozen in isopen-
tane precooled at 80°C and stored at the same temperature. Frozen 
sections (8–12 µm thick) were fixed in acetone at 20°C for 10 min and 
dried for a few hours before further processing. All antibodies were di-
luted in TBS containing 1% BSA, as stated in Table S2. Primary mouse 
monoclonal antibodies were detected with subclass-specific secondary 
antibodies  to  minimize  background.  Slides  were  mounted  in  ProLong 
Gold antifade reagent (Invitrogen; Reichelt and Magin, 2002). Antibod-
ies and dilutions are listed in Table S2. For routine histology, tissues were 
fixed overnight at 4°C in 4% formalin, sequentially incubated at 4°C over-
night in 15% and 30% sucrose, embedded in paraffin, and sectioned   
(5 µm). Sections were placed on Superfrost Plus slides (Menzel-Gläser) 
and dried. After deparaffination, sections were stained with hema-
toxylin and eosin (H&E; Reichelt and Magin, 2002).
Immunofluorescence microscopy and data processing
The  images  of  the  H&E-stained  paraffin  sections  were  acquired  using 
a fluorescence microscope (Axioplan 2; Carl Zeiss, Inc.) with a Plan- 
Neofluar 10× 0.30 NA objective and a Plan-Apochromat 63× 1.4 NA oil 
immersion objective at RT using a camera (AxioCam MR; Carl Zeiss, Inc.). 
Image analysis and processing were performed using AxioVision 4.6 (Carl 
Zeiss, Inc.) and Photoshop 6.0 (Adobe) software. Whole mount images 
were taken using a stereoscopic zoom microscope (model 1500; Nikon) 
with an HR Plan-Apochromat 1–3× zoom objective at RT using a camera 
(DS-U2/L2; Nikon). Image analysis and processing were performed with 
Photoshop  software.  Immunofluorescent  samples  were  analyzed  with  a 
fluorescence laser-scanning confocal microscope (LSM 710; Carl Zeiss, 
Inc.). For immunofluorescence microscopy and data processing, image 
stacks were collected with confocal microscope (TCS SP5; Leica) or a laser-
scanning microscope (LSM 710) with a Plan-Apochromat 63× 1.4 NA oil 
immersion objective at RT, and projection views of stacks were produced 
with the aid of Amira software (Visage Imaging). LUT (lookup table; bright-
ness and gamma) was adjusted using Photoshop. In some instances, single   
focal planes are shown.
Flow cytometry
E9.5 embryos were trypsinized, and single-cell suspensions were fixed 
in 2% PFA/PBS for 10 min at 4°C, washed with PBS, and permeabilized 
with 0.25% Triton X-100/PBS for 5 min at 4°C. The cells were washed 
and then stained for 30 min at 4°C with E-cadherin (Invitrogen) in 0.5% 
BSA/TBS  and,  after  washing,  were  labeled  with  goat  anti–rat  Alexa 
Fluor 488 (Dianova) for 15 min at 4°C. Cells were washed again and 
stained for 30 min at RT with cleaved poly(ADP-ribose) polymerase– 
phycoerythrin (BD) in 0.5% BSA/TBS. Cells were sorted on a flow fluoro-
cytometer (FACSCanto II or LSRII; BD), and data were analyzed using 
FlowJo software (Tree Star, Inc.).
Antibodies
We used antibodies against biotinylated antiavidin (Vector Laboratories), 
antidigoxigenin (Boehringer Ingelheim), K8/K18 (Progen), K19 (Troma-3; 
American Type Culture Collection), desmoplakin (gift from D. Garrod,   
University of Manchester, Manchester, England, UK), vimentin (T.M. Magin   
laboratory),  ZO-1  (Zytomed  Systems  GmbH),  occludin  (Invitrogen),   
E-cadherin (Invitrogen), ninein (gift from J.B. Rattner, University of Calgary, 
Calgary,  Alberta,  Canada),  4E-BP1,  P–4E-BP1  (Thr37/46),  p70  S6K,   
P–p70  S6K  (Thr389),  eIF2-,  P–eIF2-  (Ser51),  AMPK,  P–AMPK- 
(Thr172), Raptor, P-Raptor (Ser792), Akt, P-Akt (Ser473), P (Thr)-MAPK/
Cdk substrates (all from Cell Signaling Technology), GLUT1 (Millipore), 
GLUT3 (Alpha Diagnostic International, Inc.), Hsc70/Hsp70 (Stressgen), 
14-3-3– (Santa Cruz Biotechnology, Inc.), and secondary antibodies 
(Dianova). Dilutions are listed in Table S2.JCB • VOLUME 187 • NUMBER 2 • 2009   184
Ramírez-Solis, R., P. Liu, and A. Bradley. 1995. Chromosome engineering in 
mice. Nature. 378:720–724. doi:10.1038/378720a0
Reichelt, J., and T.M. Magin. 2002. Hyperproliferation, induction of c-Myc and 
14-3-3sigma, but no cell fragility in keratin-10-null mice. J. Cell Sci. 
115:2639–2650.
Roth, W., U. Reuter, C. Wohlenberg, L. Bruckner-Tuderman, and T.M. Magin. 
2009. Cytokines as genetic modifiers in K5-/- mice and in human epi-
dermolysis  bullosa  simplex.  Hum.  Mutat.  30:832–841.  doi:10.1002/ 
humu.20981
Schmidt, S., A. Hommel, V. Gawlik, R. Augustin, N. Junicke, S. Florian, M. 
Richter, D.J. Walther, D. Montag, H.G. Joost, and A. Schürmann. 2009. 
Essential role of glucose transporter GLUT3 for post-implantation embry-
onic development. J. Endocrinol. 200:23–33. doi:10.1677/JOE-08-0262
Schweizer,  J.,  P.E.  Bowden,  P.A.  Coulombe,  L.  Langbein,  E.B.  Lane,  T.M. 
Magin, L. Maltais, M.B. Omary, D.A. Parry, M.A. Rogers, and M.W. 
Wright. 2006. New consensus nomenclature for mammalian keratins. 
J. Cell Biol. 174:169–174. doi:10.1083/jcb.200603161
Shaw, R.J., and L.C. Cantley. 2006. Ras, PI(3)K and mTOR signalling controls 
tumour cell growth. Nature. 441:424–430. doi:10.1038/nature04869
Tamai,  Y., T. Ishikawa, M.R. Bösl, M. Mori, M. Nozaki, H. Baribault, R.G. Oshima, 
and M.M. Taketo. 2000. Cytokeratins 8 and 19 in the mouse placental de-
velopment. J. Cell Biol. 151:563–572. doi:10.1083/jcb.151.3.563
Taniguchi, M., M. Sanbo, S. Watanabe, I. Naruse, M. Mishina, and T. Yagi. 1998. 
Efficient production of Cre-mediated site-directed recombinants through 
the utilization of the puromycin resistance gene, pac: a transient gene- 
integration  marker  for  ES  cells.  Nucleic  Acids  Res.  26:679–680. 
doi:10.1093/nar/26.2.679
Thiery, J.P. 2002. Epithelial-mesenchymal transitions in tumour progression. 
Nat. Rev. Cancer. 2:442–454. doi:10.1038/nrc822
Toivola, D.M., S. Krishnan, H.J. Binder, S.K. Singh, and M.B. Omary. 2004. 
Keratins modulate colonocyte electrolyte transport via protein mistarget-
ing. J. Cell Biol. 164:911–921. doi:10.1083/jcb.200308103
Toivola, D.M., G.Z. Tao, A. Habtezion, J. Liao, and M.B. Omary. 2005. Cellular 
integrity plus: organelle-related and protein-targeting functions of inter-
mediate  filaments.  Trends  Cell  Biol.  15:608–617.  doi:10.1016/j.tcb 
.2005.09.004
Tonack, S., B. Fischer, and A. Navarrete Santos. 2004. Expression of the insulin-
responsive glucose transporter isoform 4 in blastocysts of C57/BL6 mice. 
Anat. Embryol. (Berl.). 208:225–230.
Wang, D., J.M. Pascual, H. Yang, K. Engelstad, X. Mao, J. Cheng, J. Yoo, J.L. 
Noebels, and D.C. De Vivo. 2006. A mouse model for Glut-1 haploinsuf-
ficiency. Hum. Mol. Genet. 15:1169–1179. doi:10.1093/hmg/ddl032
Wrehlke, C., W.R. Wiedemeyer, H.P. Schmitt-Wrede, A. Mincheva, P. Lichter, 
and F. Wunderlich. 1999. Genomic organization of mouse gene zfp162. 
DNA Cell Biol. 18:419–428. doi:10.1089/104454999315303
Wullschleger, S., R. Loewith, and M.N. Hall. 2006. TOR signaling in growth and 
metabolism. Cell. 124:471–484. doi:10.1016/j.cell.2006.01.016
Yang, J., and R.A. Weinberg. 2008. Epithelial-mesenchymal transition: at the 
crossroads of development and tumor metastasis. Dev. Cell. 14:818–829. 
doi:10.1016/j.devcel.2008.05.009
Ganguly, A., R.A. McKnight, S. Raychaudhuri, B.C. Shin, Z. Ma, K. Moley, and 
S.U. Devaskar. 2007. Glucose transporter isoform-3 mutations cause early 
pregnancy loss and fetal growth restriction. Am. J. Physiol. Endocrinol. 
Metab. 292:E1241–E1255. doi:10.1152/ajpendo.00344.2006
Godsel, L.M., S.N. Hsieh, E.V. Amargo, A.E. Bass, L.T. Pascoe-McGillicuddy, 
A.C. Huen, M.E. Thorne, C.A. Gaudry, J.K. Park, K. Myung, et al. 2005. 
Desmoplakin assembly dynamics in four dimensions: multiple phases 
differentially regulated by intermediate filaments and actin. J. Cell Biol. 
171:1045–1059. doi:10.1083/jcb.200510038
Gwinn, D.M., D.B. Shackelford, D.F. Egan, M.M. Mihaylova, A. Mery, D.S. 
Vasquez, B.E. Turk, and R.J. Shaw. 2008. AMPK phosphorylation of 
raptor  mediates  a  metabolic  checkpoint.  Mol.  Cell.  30:214–226. 
doi:10.1016/j.molcel.2008.03.003
Hardie, D.G. 2007. AMP-activated/SNF1 protein kinases: conserved guardians 
of cellular energy. Nat. Rev. Mol. Cell Biol. 8:774–785. doi:10.1038/ 
nrm2249
Henegariu, O., N.A. Heerema, L. Lowe Wright, P. Bray-Ward, D.C. Ward, and 
G.H. Vance. 2001. Improvements in cytogenetic slide preparation: con-
trolled chromosome spreading, chemical aging and gradual denaturing. 
Cytometry.  43:101–109.  doi:10.1002/1097-0320(20010201)43:2<101::
AID-CYTO1024>3.0.CO;2-8
Hesse, M., T. Franz, Y. Tamai, M.M. Taketo, and T.M. Magin. 2000. Targeted de-
letion of keratins 18 and 19 leads to trophoblast fragility and early embry-
onic lethality. EMBO J. 19:5060–5070. doi:10.1093/emboj/19.19.5060
Hesse, M., T.M. Magin, and K. Weber. 2001. Genes for intermediate filament 
proteins and the draft sequence of the human genome: novel keratin genes 
and a surprisingly high number of pseudogenes related to keratin genes   
8 and 18. J. Cell Sci. 114:2569–2575.
Hesse, M., A. Zimek, K. Weber, and T.M. Magin. 2004. Comprehensive analysis 
of keratin gene clusters in humans and rodents. Eur. J. Cell Biol. 83: 
19–26. doi:10.1078/0171-9335-00354
Hüsken, K., T. Wiesenfahrt, C. Abraham, R. Windoffer, O. Bossinger, and R.E. 
Leube. 2008. Maintenance of the intestinal tube in Caenorhabditis ele-
gans: the role of the intermediate filament protein IFC-2. Differentiation. 
76:881–896. doi:10.1111/j.1432-0436.2008.00264.x
Jackson, B.W., C. Grund, E. Schmid, K. Bürki, W.W. Franke, and K. Illmensee. 
1980. Formation of cytoskeletal elements during mouse embryogenesis. 
Intermediate filaments of the cytokeratin type and desmosomes in pre-
implantation embryos. Differentiation. 17:161–179. doi:10.1111/j.1432-
0436.1980.tb01093.x
Jaquemar, D., S. Kupriyanov, M. Wankell, J. Avis, K. Benirschke, H. Baribault, 
and R.G. Oshima. 2003. Keratin 8 protection of placental barrier func-
tion. J. Cell Biol. 161:749–756. doi:10.1083/jcb.200210004
Kerns, M.L., D. DePianto, A.T. Dinkova-Kostova, P. Talalay, and P.A. Coulombe. 
2007. Reprogramming of keratin biosynthesis by sulforaphane restores 
skin integrity in epidermolysis bullosa simplex. Proc. Natl. Acad. Sci. 
USA. 104:14460–14465. doi:10.1073/pnas.0706486104
Kim, S., and P.A. Coulombe. 2007. Intermediate filament scaffolds fulfill me-
chanical, organizational, and signaling functions in the cytoplasm. Genes 
Dev. 21:1581–1597. doi:10.1101/gad.1552107
Kim, S., P. Wong, and P.A. Coulombe. 2006. A keratin cytoskeletal protein regu-
lates protein synthesis and epithelial cell growth. Nature. 441:362–365. 
doi:10.1038/nature04659
Lechler, T., and E. Fuchs. 2005. Asymmetric cell divisions promote stratification 
and differentiation of mammalian skin. Nature. 437:275–280. doi:10.1038/ 
nature03922
Liao, J., D. Price, and M.B. Omary. 1997. Association of glucose-regulated pro-
tein (grp78) with human keratin 8. FEBS Lett. 417:316–320. doi:10.1016/ 
S0014-5793(97)01315-X
Lu, H., M. Hesse, B. Peters, and T.M. Magin. 2005. Type II keratins precede type I 
keratins during early embryonic development. Eur. J. Cell Biol. 84:709–
718. doi:10.1016/j.ejcb.2005.04.001
Magin, T.M., R. Schröder, S. Leitgeb, F. Wanninger, K. Zatloukal, C. Grund, and 
D.W. Melton. 1998. Lessons from keratin 18 knockout mice: formation of 
novel keratin filaments, secondary loss of keratin 7 and accumulation of 
liver-specific keratin 8-positive aggregates. J. Cell Biol. 140:1441–1451. 
doi:10.1083/jcb.140.6.1441
Magin, T.M., J. Reichelt, and M. Hatzfeld. 2004. Emerging functions: diseases 
and animal models reshape our view of the cytoskeleton. Exp. Cell Res. 
301:91–102. doi:10.1016/j.yexcr.2004.08.018
Magin, T.M., P. Vijayaraj, and R.E. Leube. 2007. Structural and regulatory func-
tions  of  keratins.  Exp.  Cell  Res.  313:2021–2032.  doi:10.1016/j.yexcr 
.2007.03.005
Nieminen, M., T. Henttinen, M. Merinen, F. Marttila-Ichihara, J.E. Eriksson, and 
S. Jalkanen. 2006. Vimentin function in lymphocyte adhesion and trans-
cellular migration. Nat. Cell Biol. 8:156–162. doi:10.1038/ncb1355
Pantaleon, M., and P.L. Kaye. 1998. Glucose transporters in preimplantation de-
velopment. Rev. Reprod. 3:77–81. doi:10.1530/ror.0.0030077